TOOKAD Trademark

Trademark Overview

On Wednesday, March 26, 2014, a trademark application was filed for TOOKAD with the United States Patent and Trademark Office. The USPTO has given the TOOKAD trademark a serial number of 79146983. The federal status of this trademark filing is Section 71 & 15 - ACCEPTED AND ACKNOWLEDGED as of Wednesday, December 8, 2021. This trademark is owned by STEBA BIOTECH N.V.. The TOOKAD trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and medicinal preparations for use in oncology; Drug delivery agents in the form of liquids that facilitate the delivery of pharmaceutical preparations; Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; Pharmaceutical preparations for the treatment in the field of oncology, for use in chemotherapy, for ocular or intraocular surgery, for use in urology, for the treatment of eye diseases and conditions, for the prevention and treatment of ocular disorders or diseases, for the treatment of kidney diseases; Potassium preparations for pharmaceutical purposes
tookad

General Information

Serial Number79146983
Word MarkTOOKAD
Filing DateWednesday, March 26, 2014
Status739 - Section 71 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateWednesday, December 8, 2021
Registration Number4757967
Registration DateTuesday, June 23, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 7, 2015

Trademark Statements

Goods and ServicesPharmaceutical and medicinal preparations for use in oncology; Drug delivery agents in the form of liquids that facilitate the delivery of pharmaceutical preparations; Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; Pharmaceutical preparations for the treatment in the field of oncology, for use in chemotherapy, for ocular or intraocular surgery, for use in urology, for the treatment of eye diseases and conditions, for the prevention and treatment of ocular disorders or diseases, for the treatment of kidney diseases; Potassium preparations for pharmaceutical purposes
Pseudo MarkTOOK AD

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 21, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSteba Biotech SA
Party Type31 - New Owner After Registration
Legal Entity Type33 - NOT AVAILABLE
AddressLuxembourg L-2613
LU
Party NameSTEBA BIOTECH N.V.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressNL
Party NameSTEBA BIOTECH N.V.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressNL
Party NameSTEBA BIOTECH N.V.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressNL

Trademark Events

Event DateEvent Description
Thursday, May 15, 2014SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Tuesday, July 1, 2014NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, May 21, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 27, 2014APPLICATION FILING RECEIPT MAILED
Friday, June 27, 2014ASSIGNED TO EXAMINER
Monday, June 30, 2014NON-FINAL ACTION WRITTEN
Wednesday, February 4, 2015NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, July 1, 2014REFUSAL PROCESSED BY MPU
Tuesday, July 1, 2014NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, July 22, 2014REFUSAL PROCESSED BY IB
Wednesday, December 24, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, January 5, 2015ASSIGNED TO LIE
Monday, January 5, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 5, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 4, 2015FINAL REFUSAL WRITTEN
Wednesday, February 4, 2015FINAL REFUSAL E-MAILED
Friday, February 27, 2015EXAMINER'S AMENDMENT ENTERED
Friday, February 27, 2015EXAMINERS AMENDMENT -WRITTEN
Friday, February 27, 2015EXAMINERS AMENDMENT E-MAILED
Friday, February 27, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, February 27, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 18, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, March 18, 2015NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Friday, April 3, 2015NOTIFICATION PROCESSED BY IB
Saturday, February 28, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, March 18, 2015NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, April 7, 2015PUBLISHED FOR OPPOSITION
Tuesday, April 7, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, September 23, 2015FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, October 20, 2015FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, June 23, 2020COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Thursday, June 25, 2020INTERNATIONAL REGISTRATION RENEWED
Tuesday, June 23, 2015REGISTERED-PRINCIPAL REGISTER
Thursday, July 2, 2015CHANGE OF OWNER RECEIVED FROM IB
Tuesday, October 20, 2015FINAL DISPOSITION PROCESSED
Tuesday, November 17, 2015FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, September 8, 2016NEW REPRESENTATIVE AT IB RECEIVED
Wednesday, December 8, 2021REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Sunday, June 13, 2021TEAS SECTION 71 & 15 RECEIVED
Monday, November 29, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, December 8, 2021NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Sunday, June 23, 2024COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

Related Keywords

tookad pharmaceutical preparations treatment delivery diseases oncology ocular urology surgery intraocular